The drug giant is selling a profitable medication to appease regulators, taking some shine off the year’s biggest pharma deal.
Business, Washington Post: Business
Mon, 06/24/2019 - 11:04am
The drug giant is selling a profitable medication to appease regulators, taking some shine off the year’s biggest pharma deal.